Free tool
FAERS Monitor: Acetaminophen
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 204957 or its brand name (Acetaminophen, Acetaminophen). Reports on generic versions are filed under their own applications.
Reports
260,681
Serious
227,384
87% of reports
Hospitalization
117,510
Death reported
51,102
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use23,638
- fatigue21,350
- drug ineffective19,003
- pain18,796
- nausea18,643
- headache17,524
- toxicity to various agents16,809
- dyspnoea15,387
- vomiting14,858
- pyrexia14,826
- arthralgia14,756
- diarrhoea14,066
- rash12,962
- pneumonia11,602
- infusion related reaction11,392
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 2,587 |
| 2005 | 2,685 |
| 2006 | 3,149 |
| 2007 | 2,550 |
| 2008 | 3,854 |
| 2009 | 2,962 |
| 2010 | 3,783 |
| 2011 | 8,055 |
| 2012 | 8,038 |
| 2013 | 3,367 |
| 2014 | 4,018 |
| 2015 | 6,103 |
| 2016 | 8,292 |
| 2017 | 7,458 |
| 2018 | 9,197 |
| 2019 | 12,626 |
| 2020 | 19,798 |
| 2021 | 20,049 |
| 2022 | 27,207 |
| 2023 | 27,954 |
| 2024 | 28,656 |
| 2025 | 28,267 |
| 2026 | 20,015 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,793,478 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| infusion related reactionSignal | 11,392 | 16.5 | 16.2 | 138,132 |
| toxicity to various agentsSignal | 16,809 | 8.8 | 8.7 | 105,794 |
| pyrexiaSignal | 14,826 | 3.6 | 3.5 | 26,653 |
| pneumoniaSignal | 11,602 | 3.0 | 2.9 | 14,759 |
| arthralgiaSignal | 14,756 | 2.9 | 2.9 | 18,482 |
| vomitingSignal | 14,858 | 2.6 | 2.6 | 14,493 |
| painSignal | 18,796 | 2.5 | 2.5 | 17,130 |
| rashSignal | 12,962 | 2.4 | 2.4 | 10,935 |
| headacheSignal | 17,524 | 2.3 | 2.3 | 12,776 |
| fatigueSignal | 21,350 | 2.2 | 2.2 | 14,917 |
| dyspnoeaSignal | 15,387 | 2.2 | 2.2 | 10,391 |
| off label useSignal | 23,638 | 2.2 | 2.2 | 15,913 |
| nausea | 18,643 | 1.9 | 1.9 | 8,369 |
| diarrhoea | 14,066 | 1.8 | 1.7 | 4,803 |
| drug ineffective | 19,003 | 1.2 | 1.1 | 471 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.